Chenguang Biotech Group (300138) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chenguang Biotech Group (300138) has a cash flow conversion efficiency ratio of 0.155x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥524.96 Million ≈ $76.82 Million USD) by net assets (CN¥3.39 Billion ≈ $495.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chenguang Biotech Group (300138) total market value for the company's overall valuation and market capitalisation.
Chenguang Biotech Group - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Chenguang Biotech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Chenguang Biotech Group Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chenguang Biotech Group ranked by their cash flow conversion efficiency. Explore cash flow quality index of Chenguang Biotech Group to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ChengDa Pharmaceuticals Co. Ltd.
SHE:301201
|
N/A |
|
HIVE Digital Technologies Ltd
NASDAQ:HIVE
|
0.032x |
|
Ardmore Shpng
NYSE:ASC
|
0.041x |
|
Asseco Business Solutions S.A.
WAR:ABS
|
0.101x |
|
Shanxi Zhendong Pharmaceutical
SHE:300158
|
-0.055x |
|
Sgis Songshan Co Ltd
SHE:000717
|
0.093x |
|
Zhe Jiang Kangsheng Co Ltd
SHE:002418
|
-0.053x |
|
Ganesh Housing Corporation Limited
NSE:GANESHHOUC
|
0.199x |
Annual Cash Flow Conversion Efficiency for Chenguang Biotech Group (2007–2024)
The table below shows the annual cash flow conversion efficiency of Chenguang Biotech Group from 2007 to 2024. View Chenguang Biotech Group stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.15 Billion ≈ $461.63 Million |
CN¥-222.81 Million ≈ $-32.60 Million |
-0.071x | +51.17% |
| 2023-12-31 | CN¥3.53 Billion ≈ $516.88 Million |
CN¥-510.91 Million ≈ $-74.76 Million |
-0.145x | -163.27% |
| 2022-12-31 | CN¥3.21 Billion ≈ $470.32 Million |
CN¥734.81 Million ≈ $107.53 Million |
0.229x | +895.84% |
| 2021-12-31 | CN¥2.78 Billion ≈ $407.30 Million |
CN¥63.90 Million ≈ $9.35 Million |
0.023x | -91.07% |
| 2020-12-31 | CN¥2.06 Billion ≈ $301.37 Million |
CN¥529.41 Million ≈ $77.47 Million |
0.257x | +1938.29% |
| 2019-12-31 | CN¥1.74 Billion ≈ $254.77 Million |
CN¥-24.35 Million ≈ $-3.56 Million |
-0.014x | +56.69% |
| 2018-12-31 | CN¥1.74 Billion ≈ $254.64 Million |
CN¥-56.18 Million ≈ $-8.22 Million |
-0.032x | +64.08% |
| 2017-12-31 | CN¥1.62 Billion ≈ $237.63 Million |
CN¥-145.95 Million ≈ $-21.36 Million |
-0.090x | +57.39% |
| 2016-12-31 | CN¥1.52 Billion ≈ $223.15 Million |
CN¥-321.62 Million ≈ $-47.06 Million |
-0.211x | -365.52% |
| 2015-12-31 | CN¥1.43 Billion ≈ $208.84 Million |
CN¥-64.66 Million ≈ $-9.46 Million |
-0.045x | -116.74% |
| 2014-12-31 | CN¥1.01 Billion ≈ $147.58 Million |
CN¥272.96 Million ≈ $39.94 Million |
0.271x | +835.08% |
| 2013-12-31 | CN¥990.39 Million ≈ $144.93 Million |
CN¥-36.47 Million ≈ $-5.34 Million |
-0.037x | +74.15% |
| 2012-12-31 | CN¥997.86 Million ≈ $146.02 Million |
CN¥-142.11 Million ≈ $-20.79 Million |
-0.142x | -267.87% |
| 2011-12-31 | CN¥968.71 Million ≈ $141.75 Million |
CN¥82.18 Million ≈ $12.03 Million |
0.085x | +141.55% |
| 2010-12-31 | CN¥933.05 Million ≈ $136.53 Million |
CN¥-190.51 Million ≈ $-27.88 Million |
-0.204x | -257.95% |
| 2009-12-31 | CN¥210.67 Million ≈ $30.83 Million |
CN¥27.23 Million ≈ $3.99 Million |
0.129x | +111.04% |
| 2008-12-31 | CN¥147.93 Million ≈ $21.65 Million |
CN¥9.06 Million ≈ $1.33 Million |
0.061x | +127.06% |
| 2007-12-31 | CN¥101.70 Million ≈ $14.88 Million |
CN¥-23.02 Million ≈ $-3.37 Million |
-0.226x | -- |
About Chenguang Biotech Group
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more